Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib — Jessica Howell (2017) | RDL Network
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib
Article 2017 en
Authors
JH
Jessica Howell
DP
David J. Pinato
RR
Ramya Ramaswami
Abstract
1 min read
The novel prognostic index of CLIP score combined with inflammatory marker RDW and treatment-related diarrhoea has good accuracy for predicting overall, 3 month and 12 month survival in patients on sorafenib.
Jessica Howell, David J. Pinato, Ramya Ramaswami, Dominik Bettinger, Tadaaki Arizumi, Cecilia Ferrari, Clarence Yen, Antonello Gibbin, Michela Emma Burlone, Giulia Guaschino, L. Sellers, James R. Black, Mario Pirisi, Masatoshi Kudo, Robert Thimme, J.‐W. Park, Rohini Sharma
Jessica Howell, David J. Pinato, Ramya Ramaswami, Tadaaki Arizumi, Cecilia Ferrari, Antonello Gibbin, Michela Emma Burlone, Giulia Guaschino, James R. Black, L. Sellers, Masatoshi Kudo, Mario Pirisi, Rajesh Sharma
Clarence Yen, Ratnadeep Sharma, Lorenza Rimassa, T. Arizumi, D. Bettinger, Huay Yee Choo, Tiziana Pressiani, M.E. Burlone, M. Pirisi, Laura Giordano, Abdulkarim Abdulrahman, Masatoshi Kudo, Robert Thimme, J.W. Park, David J. Pinato
Clarence Yen, Rohini Sharma, Lorenza Rimassa, Tadaaki Arizumi, Dominik Bettinger, Huay Yee Choo, Tiziana Pressiani, Michela Emma Burlone, Mario Pirisi, Laura Giordano, Anisa Abdulrahman, Masatoshi Kudo, Robert Thimme, Joong Won Park, David J. Pinato
Discussion(0)
No comments yet. Be the first to comment.